Clinical Trials Browser

Recruiting × INDUSTRY × mogamulizumab × Clear all

NCT07132567 2025-09-22

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

Mycosis Fungoides, Sezary Syndrome